Prostate Neoplasm Clinical Trial
Official title:
The Early Therapeutic Efficacy of The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach: A Single-Center Retrospective Cohort Study
Verified date | August 2023 |
Source | Nanjing University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this observational study was to compare the perioperative outcomes, postoperative urinary control rates and positive surgical margin (PSM) rates of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach (AP-RARP) with the Retzius-sparing approach (RS-RARP) and anterior approach (anterior-RARP) in the treatment of prostate cancer. The main question it aims to answer was: • The early therapeutic efficacy of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach Participants has been underwent: - AP-RARP - RS-RARP - anterior-RARP Researchers compared the three groups to see if AP-RARP combines the advantages of anterior and posterior RARP and is a feasible surgical option for the treatment of prostate cancer.
Status | Completed |
Enrollment | 233 |
Est. completion date | December 27, 2022 |
Est. primary completion date | May 31, 2022 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - pathologically diagnosed with prostate cancer by prostate biopsy - underwent robot-assisted laparoscopic surgery - the surgery performed by Weidong Gan - the extended pelvic lymphadenectomy (PLA) is performed on patients with high-risk prostate cancer (PSA=20 ng/ml or Grade Group 4-5 or clinical stage =T2c) and those considered to have a possibility of lymph node metastasis based on imaging evaluation. Exclusion Criteria: - Patients with a clinical and pathological TNM stage =T3b and N1 - patients with distant metastasis - urinary incontinence before surgery - received neoadjuvant therapy before surgery |
Country | Name | City | State |
---|---|---|---|
China | Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School | Nanjing | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
Nanjing University School of Medicine |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | urinary continence | was defined as using 0-1 pad a day | 0-6 month after surgery | |
Primary | positive surgical margin | observed whether the tissue cutting in surgery has tumor cell in surgical margin by pathologist | 2 weeks after surgery | |
Secondary | operating time | The start time of the operation refers to the time of incision of the skin at the surgical site. The end time of surgery refers to the time when the skin is sutured. | the day of the surgery | |
Secondary | intraoperative blood loss | Intraoperative bleeding was defined as the sum of blood content in blood gauze, blood content in negative pressure suction bottle and blood clot volume. | the day of the surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06315595 -
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion
|
||
Withdrawn |
NCT05191017 -
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
|
Phase 1/Phase 2 | |
Completed |
NCT00255125 -
Role of Soy Supplementation in Prostate Cancer Development
|
Phase 3 | |
Terminated |
NCT02809690 -
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
|
Phase 1 | |
Recruiting |
NCT03572946 -
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
|
N/A | |
Active, not recruiting |
NCT03344757 -
Health Gatherings - For Your Health After Cancer
|
N/A | |
Recruiting |
NCT05137561 -
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy
|
N/A | |
Recruiting |
NCT04792138 -
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.
|
||
Completed |
NCT03702439 -
Prostate Cancer Screening Trial Using Imaging
|
||
Completed |
NCT04852224 -
Strength, Aging, and Memory in Prostate Cancer
|
||
Completed |
NCT01240551 -
F-18 Sodium Fluoride in Prostate Cancer
|
Phase 2 | |
Not yet recruiting |
NCT06430411 -
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study
|
||
Recruiting |
NCT02436122 -
Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT03493945 -
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
|
Phase 1/Phase 2 | |
Completed |
NCT04376008 -
A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia
|
N/A | |
Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06292897 -
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
|
||
Recruiting |
NCT03819751 -
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection
|
N/A | |
Not yet recruiting |
NCT05460312 -
Protein Kinase A in Prostate Cancer Tissue.
|
||
Completed |
NCT00005916 -
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
|
Phase 2 |